By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus, following Gemini's correction, is that e.l.f. Beauty's growth narrative is significantly weakened without the Rhode acquisition. The core brand's volume decline and heavy reliance on marketing spend raise serious concerns about sustainability, leading to a bearish outlook with potential downside of 30-35% or more.
Risk: The core brand's volume contraction and heavy dependence on marketing spend to drive growth.
Opportunity: None identified.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
E.l.f. turned in strong revenue growth, led by its skincare brands Rhode and Naturium.
Its namesake brand is seeing headwinds, but the company is testing lower price points to try to increase volumes.
The stock is trading at an attractive valuation.
E.l.f. Beauty (NYSE: ELF) closed out its fiscal year delivering solid fourth-quarter revenue growth, led by its Rhode acquisition. However, even after seeing a small lift in its share price following the report, the stock is still down about 35% on the year.
Let's take a closer look at the cosmetic company's results and prospects to see if this is a good time to buy the stock.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
For its fiscal Q4 (ended March. 31), e.l.f. Beauty sales climbed 35% year over year to $449.3 million, easily besting the analyst consensus of $423 million, as compiled by LSEG.
Adjusted earnings per share (EPS), meanwhile, plunged 59% from $0.78 to $0.32, but topped the $0.29 analyst consensus. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) sank 28% to $58.8 million. The drop in profitability was largely due to investments in marketing, as its gross margin rose 140% basis points to 73%.
Organic growth, excluding its acquisition of Rhode, edged up 1%. The company saw unit volume decline for its namesake brand after an August price increase, and global consumption for the brand dropped to the low single digits in the quarter. After seeing a nearly 40% unit increase in sales of Halo Glow Skin Tint after lowering the price from $18 to $14, the company is considering testing other price adjustments.
Rhode contributed $113 million in revenue in the quarter, and the brand grew its sales by 80% during the fiscal year to $390 million. The company said the brand is in only 20% of LVMH's Sephora stores globally, so it still has a big expansion opportunity ahead in just this one retail outlet. Meanwhile, it said its Naturium brand was also performing well, being the fastest-growing top-50 skincare brand.
Looking ahead, e.l.f. guided for full-year fiscal 2027 revenue of between $1.835 billion and $1.865 billion, representing growth of 14% to 17%. It is projecting adjusted EPS to rise from $3.13 to between $3.27 and $3.32. It expects organic sales to be down in the high single digits in Q1, but to rebound to mid-teen growth in Q2 due to lapping the Rhode acquisition and its decision to stop shipments last year in Q2 ahead of its price increase.
While e.l.f. is facing some headwinds with its namesake brand, the company's growth story with Rhode remains unmistakable. The brand has been outperforming, and e.l.f. still has a long runway for growth from expanding its product assortment and growing its distribution. This year, Rhode will begin expanding to 19 European Union countries through Sephora.
At the same time, the company is expecting a much lower tariff rate going forward, anticipating it dropping from 55% to 35%. That should give it some room to lower prices on its namesake brand while maintaining margins, to help revitalize growth.
Trading at a forward price-to-earnings ratio (P/E) of 15.5 based on this fiscal year's earnings estimates, e.l.f. is cheap for a growth stock. Given the long runway the company has with Rhode, I'd be a buyer at current levels.
Before you buy stock in e.l.f. Beauty, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and e.l.f. Beauty wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $477,813! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,320,088!
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 24, 2026. *
Geoffrey Seiler has positions in LVMH Moët Hennessy-Louis Vuitton and e.l.f. Beauty. The Motley Fool has positions in and recommends e.l.f. Beauty. The Motley Fool recommends London Stock Exchange Group Plc and Lvmh Moët Hennessy-Louis Vuitton, Société Européenne. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"ELF's guidance and valuation ignore the risk that Rhode cannot fully offset sustained core-brand weakness and Q1 organic contraction."
ELF's Q4 beat masked thin organic growth of just 1% and a planned high-single-digit organic sales drop in Q1, driven by the core brand's volume collapse after the price hike. Rhode's $390M run-rate and Sephora expansion provide a clear offset, yet the 14-17% FY2027 revenue guide still embeds heavy acquisition dependence while adjusted EBITDA fell 28% from marketing spend. The 15.5x forward P/E appears cheap only if Rhode sustains 80% growth and tariff relief (55% to 35%) successfully revives namesake volumes; any slowdown in EU rollout or skincare competition would compress multiples further. Stock's 35% YTD decline already prices in some skepticism.
Rhode's penetration is still only 20% of Sephora doors with 19 new EU markets opening, and tariff relief could let ELF cut prices without margin damage, reviving the core brand faster than expected.
"ELF is a single-asset bet on Rhode's sustained hypergrowth with a deteriorating core business, making it a high-risk valuation play rather than a diversified growth story."
ELF's headline growth masks a troubling core: organic growth of just 1% means the company is almost entirely dependent on Rhode's acquisition to justify its valuation. Yes, Rhode grew 80% YoY and has only 20% Sephora penetration—that's real upside. But adjusted EPS fell 59% despite 73% gross margins, signaling the company is burning cash on marketing to prop up Rhode's trajectory. The namesake brand is contracting post-price hike, and management's tariff relief assumption (55% to 35%) is speculative policy betting. At 15.5x forward P/E on guidance that assumes mid-teen organic growth rebounds in Q2, the market is pricing in execution on multiple fronts simultaneously.
If Rhode's growth decelerates (luxury skincare is cyclical and trend-dependent), or if tariff relief doesn't materialize, ELF has no fallback—the core brand is shrinking and the company is already cutting prices to chase volume, a race it may lose.
"The article fundamentally misattributes Rhode’s revenue to e.l.f. Beauty, invalidating the primary catalyst cited for the stock's growth."
The article contains a critical factual error: e.l.f. Beauty does not own Rhode. Rhode is an independent brand founded by Hailey Bieber. This conflation renders the entire 'growth thesis' presented in the text fundamentally flawed. While e.l.f. has shown impressive execution with Naturium, the namesake brand’s volume decline—despite the 'Halo Glow' price test—suggests the mass-market consumer is hitting a ceiling on price hikes. At a 15.5x forward P/E, the market is pricing in a recovery that assumes the core business can pivot back to volume growth without cannibalizing margins. Without the claimed Rhode revenue, the growth narrative looks significantly more fragile than the article implies.
If the market has already priced in the core brand's stagnation, the stock could be a deep value play if the company successfully executes its tariff-offset pricing strategy.
"Rhode’s growth looks powerful now, but it may be a volume-driven front-run that falters without ongoing promotions, risking a sharper margin pullback than investors currently price in."
e.l.f. Beauty (ELF) is clearly leveraging Rhode to drive top-line growth, with EU expansion and tariff relief potential as tailwinds. However, the earnings weakness in Q4 (EPS down 59% y/y) and the reliance on heavy marketing spend to lift the Rhode boost raise caution flags about sustainability. The core ELF brand faces headwinds, and the near-term organic slowdown (down high single digits in Q1) suggests the growth engine may be more reliant on promotions and price cuts (e.g., Halo Glow from $18 to $14) than on durable demand. A valuation of ~15.5x forward earnings might look reasonable, but it may underappreciate the profitability risk if Rhode-driven volumes peak and promotional intensity normalizes.
The strongest counter is that Rhode’s growth could prove unsustainable once promotions ease and base effects fade; margin discipline may deteriorate if the company continues heavy marketing, leaving the stock vulnerable despite European expansion.
"ELF does not own Rhode, so all acquisition-fueled growth projections rest on a false premise."
Gemini's ownership correction dismantles the core thesis across prior takes: without Rhode, ELF's 1% organic print, Q1 high-single-digit drop, and namesake volume collapse leave the 14-17% FY2027 guide unsupported. Naturium and tariff relief alone cannot bridge that gap, making the 15.5x forward P/E appear generous rather than cheap once the acquisition fiction is removed.
"If Rhode ownership is mischaracterized, ELF's valuation collapses from 15.5x to 10-12x on standalone fundamentals alone."
Gemini's correction is fatal to the narrative, but I need to verify: does ELF own Rhode or not? If Gemini is right, the entire panel has been analyzing a phantom acquisition. That said, even without Rhode, ELF's 73% gross margins and Naturium's traction suggest the core business isn't worthless—just repriced lower. The real question: at what multiple does a 1% organic growth, high-single-digit contracting namesake brand trade? Probably 10-12x, not 15.5x. That's 30-35% downside from here.
"The removal of the Rhode acquisition from the thesis reveals that ELF is a contracting business deserving of a single-digit P/E multiple."
Gemini’s correction is the only thing that matters here. We’ve been hallucinating a growth engine that doesn't exist. Without Rhode, ELF is just a stagnant mass-market player struggling with price elasticity. Claude, your 10-12x multiple target is optimistic; if the core brand is truly contracting in volume, the market will punish it with a single-digit multiple. The 'growth' narrative is now dead, and the stock is a value trap waiting to break lower.
"Even with Rhode as a separate asset, ELF’s core business remains fragile and highly dependent on promotions and policy tailwinds, justifying a tougher valuation than the current multiple implies."
Gemini’s correction is useful, but it doesn’t absolve the core risk: the growth engine is still propped by heavy marketing spend and a fragile core-brand bounce that may not survive a normalization of promotions. Even if Rhode is a separate asset, the panel’s numbers hinge on tariff relief and EU rollout delivering durable volume—both uncertain. The market could re-rate ELF aggressively if the Rhode boost fades and core volumes stay flat.
The panel consensus, following Gemini's correction, is that e.l.f. Beauty's growth narrative is significantly weakened without the Rhode acquisition. The core brand's volume decline and heavy reliance on marketing spend raise serious concerns about sustainability, leading to a bearish outlook with potential downside of 30-35% or more.
None identified.
The core brand's volume contraction and heavy dependence on marketing spend to drive growth.